我们统计了在clinicaltrials.gov上注册的临床1期,2期和3期的肝癌药物临床试验数据。纳入统计范围的包括正在招募、招募完成和已发布招募通知的试验,没有包括已经完成、终止、未知、撤回和暂停的试验。 截止2018年6月14日,肝癌领域共有391项新药临床试验研究,临床早期研究占主导地位。其中,处于1期的有166项试验,处于2...
International Journal of Radiation Oncology*Biology*PhysicsMitchellMachtayJeffreyD.BradleyWalterJ.CurranMachtay M,Bradley JD,Curran WJ,et al.Clinical trials in thoracic radiation oncology:as easy as 1,2,3.[J].Int J Radiat Oncol Biol Phys,2014,90:490-492....
1)将以下信息收集完成后,与管理员联系并告知相关信息,由管理员进行注册。 2)请留意由ClinicalTrials.gov发送至您的邮件,并及时查看。 3)请牢记邮件中的登录名和密码并以此登录Clinical Trials.gov 系统官网及时修改密码,网址为https://register.clinicaltrials.gov/。 4)登录后,可点击Accounts中Change password修改密...
ClinicalTrials.gov 申请后 2 个工作日内创建PRS 账户通过电子邮件告知申请者如何登录PRS 。PRS账号获得后,登陆register.clinicaltrials.gov即可进行临床试验方案注册并填写试验方案信息。 临床试验方案信息单元填写 打开clinicaltrials.gov/界面后,输入单位信息(Organization), 用户名和密码后,进入临床试验注册界面。填写的...
CLINICAL TRIALS The benefits of vitamins to our well-being are now familiar to most; however, when the link between diets lacking in citrus fruits and the development of the affliction ‘scurvy’ in sailors was first discovered by James Lind in 1747, the concept of vitamins was yet to be ...
1)将以下信息收集完成后,与管理员联系并告知相关信息,由管理员进行注册。 2)请留意由ClinicalTrials.gov发送至您的邮件,并及时查看。 3)请牢记邮件中的登录名和密码并以此登录Clinical Trials.gov 系统官网及时修改密码,网址为https://register.clinicaltrials.gov/。
Clinical trials are research studies with volunteers designed to learn more about how our bodies respond to potential new medicines or treatments. We’re grateful to the thousands of volunteers who participate in our clinical trials — making our research possible. Find a trial What...
Our work in clinical trialsRead our stories We use the power of leading-edge science to save and improve lives around the world. See the stories behind our work. slide 3 to 5 of 2 VIDEO: Patient with PAH shares her clinical trial experience Diagnosed with pulmonary arterial hypertension, ...
--Genprex, Inc., a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced positive clinical study updates for its Acclaim-1 and Acclaim-3 clinical trials for the treatment
根据全球临床试验收录网站clinicaltrials和中国临床试验登记平台chinadrugtrials,5月共有16款创新药首次进入III期临床阶段,其中11款来自国内企业。本文筛选其中9款产品加以介绍。 注:1.信息来源于Clinicaltrials和Chinadrugtrials。 2.仅登记创新药,微创新和生物类似药不包括在内。